Cardiac Antigen Identified as Mechanism for Heart Complication

(HEALTH NEWS) Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint inhibitors. Although the adverse event is rare — affecting less than 1% of patients given the immunotherapy — the mortality rate is nearly 50%.
Now, researchers from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation.
The researchers discovered that T-cells recognizing the cardiac antigen α-myosin are the mechanism for this ...

Related Keywords

Houston ,Texas ,United States ,Jordan ,Wouter Meijers ,Yueli Zhang ,Ayaka Sugiura ,Javid Moslehi ,Xiaopeng Sun ,Warren Tai ,Susan Opalenik ,Juan Qin ,Jeffrey Rathmell ,Jamesc Bradford Jr ,Abigail Toren ,Margaret Axelrod ,Jamesp Allison ,Brandie Taylor ,Elie Tannous ,Douglas Johnson ,Elizabeth Phillips ,Ann Hanna ,Kaushik Amancherla ,Simon Mallal ,P Brent Ferrell ,Vanderbilt Ingram Cancer Center ,Fund In Melanoma Cancer Research ,National Institutes Of Health ,Md Anderson Cancer Center ,Van Stephenson Memorial Cancer Research Fund ,Balko Lab ,Ingram Associate Professor Of Cancer Research ,Vanderbilt Medical Scientist Training Program ,New England Journal ,Justin Balko ,Ingram Associate Professor ,Cancer Research ,Cancer Center ,Cancer Discovery ,Luke Simons Directorship ,Melanoma Cancer Research ,National Institutes ,Elles Screever ,Mary Grace Carroll ,Jordan Wright ,Hear Condition ,Heart Inflamation ,Myocarditis ,Rutherford County ,Tennessee ,Vanderbilt ,